The short answer
After multiple myeloma treatment, follow-up should cover surveillance, late effects, recurrence worries, practical needs, and a written survivorship plan.
Which questions matter for multiple myeloma depends on the specifics named below, not on a general checklist.
The next step depends on diagnosis, symptoms, goals, prior results, and what is still pending.
Use the page to prepare specific questions for a clinician who can review the full record.
Choose how you want to understand this
The full explanation.
The short answer
Survivorship after multiple myeloma means follow-up for recurrence, late effects, symptoms, emotional health, and daily life after treatment.
This page is not a prediction. It is a practical guide to the questions people often need when multiple myeloma enters this part of care.
What changes at this point
The focus shifts from active treatment logistics to monitoring, recovery, late effects, prevention, rehabilitation, and knowing when to call.
The most helpful next step is to ask the team to name the goal out loud: cure, long-term control, symptom relief, preventing recurrence, preserving function, or gaining time with acceptable quality of life.
Information that shapes the plan
Myeloma is usually a long-term condition you live with rather than finish, so follow-up means staying on maintenance therapy, protecting your bones and kidneys, preventing infections, and rechecking your paraprotein numbers every month or two.
If a result is pending, ask whether it could change the plan. If it could, ask whether treatment should wait, start now, or use a bridge plan while the result is pending.
Questions to bring
- How often are my blood and urine checked - M protein, free light chains, creatinine, calcium and blood counts - and who calls me with the results?
- How long do I stay on lenalidomide maintenance, and what is the risk of a second cancer such as MDS or leukemia from years of treatment?
- Am I MRD-negative on my bone marrow test, and does that change how long I stay on treatment?
- Which vaccines do I need - flu, COVID, pneumococcal, RSV, shingles - and do I need IVIG if my normal antibody levels are low?
- Should I be on acyclovir to prevent shingles while I am on bortezomib or daratumumab?
- How long do I stay on zoledronic acid or denosumab, and what dental care do I need first to avoid jaw problems (osteonecrosis)?
- I have lasting numbness and burning in my feet from bortezomib - what can be done, and do I have compression fractures that would benefit from kyphoplasty or radiation?
It is reasonable to ask the team to slow down, repeat the answer, write the plan in the after-visit summary, or explain which decision is urgent and which can wait.
Second opinion and trial questions
A second opinion is especially useful when the cancer is rare, the plan may change quality of life, major surgery is being considered, biomarkers are incomplete, a clinical trial may be relevant, or the choice feels preference-sensitive.
Ask whether the case should be reviewed at a tumor board, whether all standard options are still available, and whether trial eligibility depends on timing.
Support and daily life
Care decisions affect work, transportation, meals, caregiving, money, sex, fertility, sleep, and mood. Ask for a social worker or navigator early, not only after a crisis.
Related pages
Helpful starting points include Cancer Staging, Biomarker Testing, Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor.
Where this comes from
These questions were drawn from current patient guidance for multiple myeloma:
Words to know
Tap any term to see what it means.
Common questions
Does this page tell me what treatment to choose?
No. It explains the topic in plain language so you can ask better questions. Your care team applies it to your diagnosis, test results, and goals.
What should I bring to the visit?
Bring the report, medicine list, recent test results, and a written list of questions. Ask what result or decision is still pending.
When is this more urgent?
Use the urgent instructions from your care team for severe, fast-changing, or treatment-specific warning symptoms.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- What Is Multiple Myeloma?
- Cancer Staging: What the Stage Means
- Biomarker Testing and Precision Medicine
- Getting a Second Opinion After a Diagnosis
- Questions to Ask About Multiple myeloma Treatment
- Multiple myeloma Recurrence: What to Ask
- Multiple myeloma: Relapsed or Refractory Questions
- Cancer Survivorship and Life After Treatment
Still have questions?
Educational answers, plain language
Free to print and share